The Role of Omics Approaches to Characterize Molecular Mechanisms of Rare Ovarian Cancers: Recent Advances and Future Perspectives
Rare ovarian cancers are ovarian cancers with an annual incidence of less than 6 cases per 100,000 women. They generally have a poor prognosis due to being delayed diagnosis and treatment. Exploration of molecular mechanisms in these cancers has been challenging due to their rarity and research effo...
Main Authors: | Yashwanth Subbannayya, Riccardo Di Fiore, Silvana Anna Maria Urru, Jean Calleja-Agius |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/10/1481 |
Similar Items
-
(In)Distinctive Role of Long Non-Coding RNAs in Common and Rare Ovarian Cancers
by: Maja Sabol, et al.
Published: (2021-10-01) -
Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis
by: Yinan Xiao, et al.
Published: (2022-05-01) -
What rare cancers have in common. The making of lists of (very) rare cancers and the coordination of medical work
by: Héloïse Pillayre, et al.
Published: (2023-08-01) -
Non-Gestational Ovarian Choriocarcinoma: A Rare Ovarian Cancer Subtype
by: Sean Cronin, et al.
Published: (2022-02-01) -
Editorial: AI and multi-omics for rare diseases: challenges, advances and perspectives, Volume III
by: Frank Emmert-Streib, et al.
Published: (2024-03-01)